Serum IGFBP-2 in Systemic Sclerosis as a Protective Factor of Lung Dysfunction
Julien Guiot(University of Liège), Renaud Louis(University of Liège)
Cited by 0
Related Papers
“Real-life” effectiveness of omalizumab in patients with severe persistent allergic asthma: The PERSIST study
|Respiratory Medicine|2009|198